What is the diagnosis and appropriate management for a patient with iron saturation 8 %, hemoglobin 10.5 g/dL, mean corpuscular hemoglobin 26.1 pg, mean corpuscular hemoglobin concentration 30.9 g/dL, and red cell distribution width 15.6 %?

Iron Deficiency Anemia

This patient has iron deficiency anemia (IDA) and should be started on oral iron supplementation with 50-100 mg elemental iron daily (e.g., one ferrous sulfate 200 mg tablet), taken on an empty stomach, with monitoring of hemoglobin response after 2 weeks. 1

Diagnosis

The laboratory values confirm IDA:

• Hemoglobin 10.5 g/dL indicates anemia (normal >12 g/dL in women, >13 g/dL in men) 2
• Iron saturation 8% is markedly low (normal >20%), confirming absolute iron deficiency 1, 3
• MCH 26.1 pg and MCHC 30.9 g/dL are both reduced, indicating hypochromic red cells characteristic of iron deficiency 4, 3
• RDW 15.6% is elevated, reflecting increased variation in red cell size (anisocytosis) that develops early in iron deficiency, even before anemia becomes evident 5

These parameters collectively demonstrate classic IDA with iron-deficient erythropoiesis 3.

Initial Management

Start oral iron therapy immediately:

• Ferrous sulfate 200 mg once daily (providing 65 mg elemental iron) is the most cost-effective first-line option 1
• Take on an empty stomach for optimal absorption; if not tolerated, may take with meals (preferably with meat protein and 500 mg vitamin C to enhance absorption) 6
• Alternative formulations include ferrous fumarate or ferrous gluconate if ferrous sulfate is not tolerated 1

Monitor response at 2 weeks:

• Hemoglobin should rise by at least 10 g/L (1 g/dL) after 2 weeks of daily oral iron therapy 1
• Failure to achieve this response has 90.1% sensitivity and 79.3% specificity for predicting subsequent treatment failure 1

Alternative Dosing Strategy

If gastrointestinal side effects occur (nausea, abdominal pain, constipation):

• Alternate-day dosing (60 mg elemental iron every other day) is as effective as daily dosing with significantly fewer side effects 1, 7
• Ferric maltol 30 mg twice daily is better tolerated than traditional iron salts, though more expensive 1

When to Consider Intravenous Iron

Switch to IV iron if: 6, 1

• No hemoglobin response after 2 weeks of adequate oral therapy
• Intolerance to multiple oral iron formulations
• Malabsorption conditions
• Ongoing blood loss exceeding oral replacement capacity
• Severe anemia with hemoglobin <7 g/dL requiring rapid correction

Essential Workup Required

Investigate the underlying cause of iron deficiency: 6

• Gastrointestinal evaluation (upper and lower endoscopy) is indicated for all adults with IDA, particularly men and postmenopausal women, to exclude GI blood loss or malabsorption
• Assess for celiac disease (tissue transglutaminase antibodies)
• Review menstrual history in premenopausal women
• Evaluate dietary iron intake
• Test for Helicobacter pylori infection 6

Common Pitfalls

• Do not switch between different oral iron salts (ferrous sulfate to ferrous fumarate) for intolerance—this is not evidence-based; instead, try alternate-day dosing or ferric maltol 1
• Do not use modified-release preparations—they are less suitable for prescribing due to reduced bioavailability 1
• Blood transfusion is rarely indicated for IDA unless severe symptomatic anemia or circulatory compromise is present; IV iron produces meaningful hemoglobin response within one week 1
• Hemoglobin and MCV alone are poor screening tools—more than 50% of women with documented IDA are neither anemic nor microcytic at diagnosis 8

Follow-up

Continue iron supplementation for 3-6 months after hemoglobin normalizes to replenish iron stores 6, 2. Recheck complete blood count and consider ferritin measurement to confirm adequate repletion.